Stay updated on EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.

Latest updates to the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedThe revision history now lists v3.6.5 instead of v3.6.4, reflecting a new interface release. This indicates an update to the ClinicalTrials.gov release notes for the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe history now shows a new site revision entry, v3.6.4, replacing the previous revision v3.6.3, reflecting an updated release of the interface.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedA new history revision entry (v3.6.3) has been added, replacing the previous revision (v3.6.2) to reflect an updated submission for the study record.SummaryDifference0.1%

- Check47 days agoChange DetectedA new Revision: v3.6.2 was added to the Study Record History and Revision: v3.6.0 was removed, updating the version history to reflect the latest revision.SummaryDifference0.1%

- Check61 days agoChange DetectedThe history now shows that the study is no longer seeking participants. The record has been updated to revision v3.6.0, replacing the previous revision v3.5.5.SummaryDifference0.4%

- Check68 days agoChange DetectedA new revision (v3.5.5) was added to the record history, and the previous revision (v3.5.4) was removed. This update documents changes to the historical record of the study page.SummaryDifference0.1%

Stay in the know with updates to EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.